CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop off-the-shelf regulatory T cell products for treating autoimmune diseases and organ transplant rejection. By utilizing human induced pluripotent stem cells and a novel epigenetic editing method, it seeks to create universally applicable Treg therapies without the need for patient-specific c…
Regulatory T cells (Treg) are a type of immune cell that can suppress harmful inflammation caused by autoimmune diseases or organ transplant rejection.
Using Treg as a living drug is a promising form of precision medicine, but it faces many practical and economic challenges, such as the need to produce a specific cell product for each patient. A more feasible solution would be to create off-the-shelf Treg products that are readily available and can be used universally without customizing them fo…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
